Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Stroke. 2003;34:387-391
Published online before print January 16, 2003, doi: 10.1161/01.STR.0000054057.11892.5B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/2/387    most recent
01.STR.0000054057.11892.5Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnsen, S. P.
Right arrow Articles by Sørensen, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnsen, S. P.
Right arrow Articles by Sørensen, H. T.
Related Collections
Right arrow Platelet function inhibitors
Right arrow Acute Cerebral Hemorrhage
Right arrow Rehabilitation, Stroke

(Stroke. 2003;34:387.)
© 2003 American Heart Association, Inc.

Original Contributions

Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage

A Population-Based Case-Control Study

Søren P. Johnsen, MD; Lars Pedersen, MSc; Søren Friis, MD; William J. Blot, PhD; Joseph K. McLaughlin, PhD; Jørgen H. Olsen, DMSc Henrik T. Sørensen, DMSc

From the Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, and Aalborg Hospital, Aalborg, Denmark (S.P.J., L.P., H.T.S.); Department of Epidemiology and Social Medicine, University of Aarhus, Denmark (S.P.J.); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (S.F., J.H.O.); International Epidemiology Institute, Rockville, Md (W.J.B., J.K.M); Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tenn (W.J.B., J.K.M., J.H.O.); Department of Medicine M, Aalborg Hospital, Aalborg, Denmark (H.T.S.); and Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark (H.T.S.).

Correspondence to Søren Paaske Johnsen, MD, Department of Clinical Epidemiology at Aarhus University Hospital and Aalborg Hospital, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark. E-mail: spj{at}soci.au.dk

Background and Purpose— Nonsteroidal anti-inflammatory drugs (NSAIDs) have effects on hemostasis and have been associated with an increased risk of bleeding. However, data relating the use of nonaspirin NSAIDs and risk of intracerebral hemorrhage (ICH) are sparse.

Methods— Using data from the County Hospital Patient Register and the Civil Registration System of North Jutland County, Denmark, we identified 912 cases of first-time ICH and 9059 sex- and age-matched population-based controls in the period of 1991 to 1999. All prescriptions for nonaspirin NSAIDs before the date of admission for ICH were identified through a population-based prescription database. Conditional logistic regression was used to adjust for potential confounding factors, including previous discharge diagnoses of hypertension, chronic bronchitis and emphysema, alcoholism, liver cirrhosis, diabetes mellitus, and prescriptions for insulin or oral hypoglycemic agents, antihypertensive agents, lipid-lowering agents, low-dose aspirin, high-dose aspirin, and oral anticoagulants.

Results— No overall association was found between prescription for nonaspirin NSAIDs in the preceding 30, 60, or 90 days and risk of ICH; ie, odds ratios ranged from 0.92 (95% CI, 0.70 to 1.21) to 1.13 (95% CI, 0.81 to 1.58). Furthermore, there was no increased risk of ICH associated with prescription for nonaspirin NSAIDs when the study population was stratified by age, sex, and a previous discharge diagnosis of hypertension.

Conclusions— Patients prescribed nonaspirin NSAIDs were not at an overall increased risk of being hospitalized for ICH. This reassuring finding was seen in all examined subgroups, including the elderly and patients with a previous discharge diagnosis of hypertension.


Key Words: anti-inflammatory agents, nonsteroidal • case-control studies • epidemiology • intracerebral hemorrhage




This article has been cited by other articles:


Home page
 Arch Intern MedHome page
M. D. M. Haag, M. J. Bos, A. Hofman, P. J. Koudstaal, M. M. B. Breteler, and B. H. C. Stricker
Cyclooxygenase Selectivity of Nonsteroidal Anti-inflammatory Drugs and Risk of Stroke
Arch Intern Med, June 9, 2008; 168(11): 1219 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
N.-K. Choi, B.-J. Park, S.-W. Jeong, K.-H. Yu, and B.-W. Yoon
Nonaspirin Nonsteroidal Anti-inflammatory Drugs and Hemorrhagic Stroke Risk: The Acute Brain Bleeding Analysis Study
Stroke, March 1, 2008; 39(3): 845 - 849.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. T. Chan, J. E. Manson, C. M. Albert, C. U. Chae, K. M. Rexrode, G. C. Curhan, E. B. Rimm, W. C. Willett, and C. S. Fuchs
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Circulation, March 28, 2006; 113(12): 1578 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. Juvela, D. Gaist, S. Bak, S. P. Johnsen, L. Pedersen, H. T. Sorensen, S. Friis, J. H. Olsen, W. J. Blot, and J. K. McLaughlin
Nonsteroidal Anti-Inflammatory Drugs as Risk Factors for Spontaneous Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage * Response
Stroke, June 1, 2003; 34 (6): e34 - e36.
[Full Text] [PDF]


Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.